Sustained interest in small molecules, bispecific antibodies, and genomics got the ball rolling in the biotech deals arena in ...
The upcoming drugs CagriSema and retatrutide target multiple gut hormones and could cause twice as much weight loss than ...
Clinical Trials Arena on MSN
AiCuris reports positive Phase III pritelivir results for HSV patients
The trial enrolled and treated 101 immunocompromised patients with refractory or resistant HSV infection.
People may be able to pay less for prescriptions with their insurance rather than via the new government website. The Trump ...
At a starting cost of just $49 per month, the new pills are the cheapest GLP-1 option yet. But experts say compounded drugs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results